As women around the world embark on the war on cancer, the good news about breast cancer is tempered by predictions that deaths from lung cancer may increase more than 40 percent.
Researchers in Spain reported that between 2015 and 2030, deaths from lung cancer among women worldwide are likely to increase by 43 percent.
However, during that same period, deaths from breast cancer are expected to decrease by 9 percent.
“While we have made great strides in reducing breast cancer mortality globally, mortality rates from lung cancer among women are increasing worldwide,” said study author José Martínez-Sánchez . He is director of public health, epidemiology and biostatistics of the International University of Catalonia (UIC Barcelona).
For the study, the researchers analyzed data from the World Health Organization collected from 52 countries between 2008 and 2014. The authors of the study concluded that the global death rate from lung cancer will increase from just over 11 percent in 2015 to 16 percent in 2030.
The highest rates in 2030 are projected in Europe and Oceania, and the lowest rates in North America and Asia. Only Oceania is expected to experience a decline in the death rate of women with lung cancer, and that is only 17.8 percent in 2015 to 17.6 percent in 2030.
“If we do not implement measures to reduce smoking behavior in this population, lung cancer mortality will continue to rise worldwide,” Martínez-Sánchez warned in a press release from the magazine.
Meanwhile, he said, “we are seeing an increase in breast cancer mortality in Asia because this culture is adapting a westernized lifestyle, which often leads to obesity and increased alcohol consumption, which can lead to cancer. mom”.
Breast cancer is associated with many lifestyle factors, explained Martínez-Sánchez.
“On the other hand, we are witnessing a decrease in mortality from breast cancer in Europe,” he added. There may be a greater awareness about breast cancer among Europeans, he suggested, leading to active participation in screening programs and improvements in treatment.
The study was published in the journal Cancer Research.